Jeffrey Hackman
Algemeen Directeur bij Comera Life Sciences, Inc.
Vermogen: 1 095 $ op 31-05-2024
Profiel
Jeffrey S Hackman currently works at Comera Life Sciences, Inc., as Chairman & Chief Executive Officer.
Mr. Hackman also formerly worked at Comera Life Sciences Holdings, Inc., as Chairman, President & Chief Executive Officer, Leadiant Biosciences, Inc., as Chief Operating Officer & Director, Sigma-tau Healthscience USA, Inc., as Chief Operating Officer & Director, Shire Plc, as SVP-US Internal Medicine & Oncology franchise, Baxalta US, Inc., as Vice President & Head-North America Region, and Novelion Therapeutics, Inc., as Chief Executive & Operating Officer, Executive VP from 2017 to 2018.
Mr. Hackman received his undergraduate degree from Lycoming College.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
27-09-2023 | 47 600 ( 0.15% ) | 1 095 $ | 31-05-2024 |
Actieve functies van Jeffrey Hackman
Bedrijven | Functie | Begin |
---|---|---|
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | Algemeen Directeur | 08-09-2021 |
Eerdere bekende functies van Jeffrey Hackman
Bedrijven | Functie | Einde |
---|---|---|
COMERA LIFE SCIENCES HOLDINGS, INC. | Algemeen Directeur | 31-01-2024 |
NOVELION THERAPEUTICS INC. | Algemeen Directeur | 20-11-2018 |
Sigma-tau Healthscience USA, Inc.
Sigma-tau Healthscience USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Essetifin SpA, Sigma-tau Healthscience USA, Inc. provides health solutions that focus on mitochondrial functioning. Sigma-tau Healthscience USA is based in Gaithersburg, MD. Mitochondria are the energy factories of cells, and healthy mitochondria contribute to various health benefits. Sigma-tau Healthscience USA's Mitocarn™ provides healthy mitochondrial functioning in three ways: by providing energy to the body, supporting mitochondrial function, and strengthening core cellular functions. The company offers four targeted L-carnitine solutions, including Mitocarn™ Heart, which provides extra energy to heart cells during the metabolic process and helps increase blood flow to the heart and muscles. | Operationeel Directeur | - |
Baxalta US, Inc.
Baxalta US, Inc. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Baxalta US, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The company is based in Deerfield, IL. | Corporate Officer/Principal | - |
SHIRE | Corporate Officer/Principal | - |
Opleiding van Jeffrey Hackman
Lycoming College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
COMERA LIFE SCIENCES HOLDINGS, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Health Technology |
Baxalta US, Inc.
Baxalta US, Inc. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Baxalta US, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The company is based in Deerfield, IL. | Health Technology |
Novelion Therapeutics, Inc.
Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
Sigma-tau Healthscience USA, Inc.
Sigma-tau Healthscience USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Essetifin SpA, Sigma-tau Healthscience USA, Inc. provides health solutions that focus on mitochondrial functioning. Sigma-tau Healthscience USA is based in Gaithersburg, MD. Mitochondria are the energy factories of cells, and healthy mitochondria contribute to various health benefits. Sigma-tau Healthscience USA's Mitocarn™ provides healthy mitochondrial functioning in three ways: by providing energy to the body, supporting mitochondrial function, and strengthening core cellular functions. The company offers four targeted L-carnitine solutions, including Mitocarn™ Heart, which provides extra energy to heart cells during the metabolic process and helps increase blood flow to the heart and muscles. | Health Technology |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | Health Technology |